Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06441812 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Study to Evaluate the Long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients

StatusRecruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗

Record History

  1. Trial status: Not Yet Recruiting to Recruiting Primary and study completion dates: Dec 2027 to Sep 2028 · Study sites: 0 to 1 · Start date changed from estimate of Jun 2024 to Jul 19, 2024 · 1 morev2 Show 4 more changesShow less
    • Primary and study completion dates: Dec 2027 to Sep 2028
    • Study sites: 0 to 1
    • Start date changed from estimate of Jun 2024 to Jul 19, 2024
    • Eligibility criteria shortened, about 7 words

    See this version in full on ClinicalTrials.gov ↗

  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to evaluation the long-term Safety, Pharmacodynamics and Efficacy of SHR-1703 in Eosinophilic Asthma Patients
Trial Details
NCT Number NCT06441812
Lead Sponsor Guangdong Hengrui Pharmaceutical Co., Ltd
Conditions Eosinophilic Asthma Patients
Enrollment 200 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov